Last $186.22 USD
Change Today +2.72 / 1.48%
Volume 378.4K
ILMN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for illumina inc (ILMN)

Although debt as a percent of total capital decreased at Illumina Inc. over the last fiscal year to 36.16%, it is still in-line with the Life Sciences Tools and Services industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 57.73 days worth of sales outstanding. Last, inventory levels, relative to the Cost of Goods Sold, are typical for the industry but have shown a consistent increase during the last 4 years. This implies a potential loss of efficiency or pricing power.
Currency in
Millions of US Dollars
As of:Jan 02
2011
Reclassified
Jan 01
2012
Reclassified
Dec 30
2012
Reclassified
Dec 29
2013
4 Year
Trend
Assets    
Cash and Equivalents248.9303.0434.0711.6
Short-Term Investments645.3886.6916.2454.0
TOTAL CASH AND SHORT TERM INVESTMENTS894.31,189.61,350.21,165.6
Accounts Receivable163.4171.2213.1237.7
Other Receivables2.22.71.91.3
TOTAL RECEIVABLES165.6173.9215.0238.9
Inventory142.2128.8158.7154.1
Prepaid Expenses36.929.232.722.8
Deferred Tax Assets, Current19.423.230.536.1
TOTAL CURRENT ASSETS1,258.41,544.61,787.01,617.5
Gross Property Plant and Equipment233.5280.2319.6380.2
Accumulated Depreciation-103.6-136.7-153.4-177.5
NET PROPERTY PLANT AND EQUIPMENT129.9143.5166.2202.7
Goodwill278.2321.9369.3723.1
Long-Term Investments32.045.356.322.1
Deferred Tax Assets, Long Term39.519.740.288.5
Other Intangibles91.5106.5130.2331.2
Other Long-Term Assets9.714.416.934.0
TOTAL ASSETS1,839.12,195.82,566.13,019.0
    
LIABILITIES & EQUITY    
Accounts Payable66.749.865.773.7
Accrued Expenses61.668.572.4101.6
Current Portion of Long-Term Debt/Capital Lease311.6--37.029.3
Current Income Taxes Payable13.319.323.030.4
Other Current Liabilities, Total35.436.750.636.3
Unearned Revenue, Current45.952.655.850.8
TOTAL CURRENT LIABILITIES534.5226.9304.6322.1
Long-Term Debt--807.4805.4839.3
Other Non-Current Liabilities106.986.3137.5324.4
TOTAL LIABILITIES641.41,120.61,247.51,485.8
Common Stock1.51.71.71.8
Additional Paid in Capital1,891.32,249.92,419.82,562.7
Retained Earnings-155.3-68.782.5207.9
Treasury Stock-541.6-1,109.8-1,187.6-1,240.3
Comprehensive Income and Other1.82.12.11.2
TOTAL COMMON EQUITY1,197.71,075.21,318.61,533.2
TOTAL EQUITY1,197.71,075.21,318.61,533.2
TOTAL LIABILITIES AND EQUITY1,839.12,195.82,566.13,019.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $186.22 USD +2.72

ILMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Avago Technologies Ltd $100.72 USD -0.06
Becton Dickinson and Co $139.90 USD +1.44
Dr Reddy's Laboratories Ltd 3,134 INR -71.90
Sigma-Aldrich Corp $137.16 USD -0.01
Waters Corp $114.54 USD +0.21
View Industry Companies
 

Industry Analysis

ILMN

Industry Average

Valuation ILMN Industry Range
Price/Earnings 99.7x
Price/Sales 15.4x
Price/Book 21.1x
Price/Cash Flow 84.4x
TEV/Sales 14.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.